Beyond Body Mass Index: Advantages of Abdominal Measurements for Recognizing Cardiometabolic Disorders
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields



Publication Date Range:


Document Data


Document Type:






Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page


Beyond Body Mass Index: Advantages of Abdominal Measurements for Recognizing Cardiometabolic Disorders

Filetype[PDF-673.64 KB]


  • Alternative Title:
    Am J Med
  • Description:

    The clinical recognition of cardiometabolic disorders might be enhanced by anthropometry based on the sagittal abdominal diameter (SAD; also called “abdominal height”) or waist circumference rather than on weight. Direct comparisons of body mass index (BMI, weight/height2) with SAD/height ratio (SADHtR) or waist circumference/height ratio (WHtR) have not previously been tested in nationally representative populations.


    Nonpregnant adults without diagnosed diabetes (ages 20–64 years; n = 3071) provided conventional anthropometry and supine SAD (by sliding-beam caliper) in the 2011–2012 US National Health and Nutrition Examination Survey. Population-weighted, logistic models estimated how strongly each anthropometric indicator was associated with 5 cardiometabolic disorders: Dysglycemia (glycated hemoglobin ≥5.7%), HyperNonHDLc (non-high-density-lipoprotein [HDL] cholesterol ≥4.14 mmol/L, or taking anticholesteremic medications), Hypertension (systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg, or taking antihypertensive medications), HyperALT (alanine transaminase ≥p75 [75th percentile, sex-specific]), and HyperGGT (gamma-glutamyltransferase ≥p75 [sex-specific]).


    After scaling each indicator, adjusted odds ratios (aORs) tended to be highest for SADHtR and lowest for BMI when identifying each disorder except dysglycemia. When SADHtR entered models simultaneously with BMI, the aORs for BMI no longer directly identified any condition, whereas SADHtR identified persons with HyperNonHDLc by aOR 2.78 (95% confidence interval [CI], 1.71–4.51), Hypertension by aOR 2.51 (95% CI, 1.22–5.15), HyperALT by aOR 2.89 (95% CI, 1.56–5.37), and HyperGGT by aOR 5.43 (95% CI, 3.01–9.79). WHtR competed successfully against BMI with regard to Dysglycemia, Hyper-NonHDLc, and HyperGGT. c-Statistics of SADHtR and WHtR were higher than those of BMI (P <.001) for identifying HyperNonHDLc and HyperGGT.


    Among nonelderly adults, SADHtR or WHtR recognized cardiometabolic disorders better than did the BMI.

  • Pubmed ID:
  • Pubmed Central ID:
  • Document Type:
  • Collection(s):
  • Main Document Checksum:
  • File Type:

You May Also Like

Checkout today's featured content at